Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: JOHN W. who wrote (3616)	1/14/1998 10:22:00 PM
From: Peter Singleton	Respond to of 6136

John, in posting the CBOE AGPH option trades today, were you highlighting the heavy trading in in-the-money January calls? It looks like 470 contracts for January 30s were traded (at a price somewhere around $450 per contract) and 628 contracts for January 35s (at a price around $50 per contract). Of lesser note, 272 Feb 35s were traded at a price around $275 per. Do any of you options guys have an opinion about these trades? Is this normal trading activity for in the money calls just before expiration ... and can we infer anything from the trades? I know enough about options to lose a little money every once in awhile when I think I know how to time the market ... but that's about it. Peter